Related references
Note: Only part of the references are listed.Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines
Paul Nyirjesy et al.
CLINICAL INFECTIOUS DISEASES (2022)
The investigation of in vitro effects of farnesol at different cancer cell lines
Betul Yilmaz Ozturk et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2022)
Farnesol Boosts the Antifungal Effect of Fluconazole and Modulates Resistance in Candida auris through Regulation of the CDR1 and ERG11 Genes
Jaroslava Dekkerova et al.
JOURNAL OF FUNGI (2022)
Marine Compounds with Anti-Candida sp. Activity: A Promised Land for New Antifungals
Anelise Maria Costa Vasconcelos Alves et al.
JOURNAL OF FUNGI (2022)
Expression pattern of drug-resistance genes ERG11 and TAC1 in Candida albicans Clinical isolates
Majid Zare-Bidaki et al.
MOLECULAR BIOLOGY REPORTS (2022)
Overview on the Infections Related to Rare Candida Species
Sunil Kumar et al.
PATHOGENS (2022)
Morphological characteristics of Candida albicans, Candida krusei, Candida guilliermondii, and Candida glabrata biofilms, and response to farnesol
Nadezhda Sachivkina et al.
VETERINARY WORLD (2021)
Farnesol: An approach on biofilms and nanotechnology
Adelaide Fernandes Costa et al.
MEDICAL MYCOLOGY (2021)
A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women
Amir Arastehfar et al.
FRONTIERS IN MICROBIOLOGY (2021)
In vivo antifungal activity of farnesol combined with antifungal drugs on oral mucosal candidiasis in mice
Chengxi Li et al.
BIOFOULING (2021)
Pharmacological applications of farnesol (C15H26O): a patent review
Gyllyandeson De Araujo Delmondes et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris
Fruzsina Nagy et al.
FRONTIERS IN MICROBIOLOGY (2020)
Farnesol and Tyrosol: Secondary Metabolites with a Crucial quorum-sensing Role in Candida Biofilm Development
Celia F. Rodrigues et al.
GENES (2020)
Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole
Camila Fonseca Bezerra et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2020)
Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives
Valentina Sustr et al.
JOURNAL OF FUNGI (2020)
Autologous plasma versus fetal calf serum as a supplement for the culture of neutrophils
Razieh Alipour et al.
BMC RESEARCH NOTES (2020)
Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Candida albicans
Lucia Cernakova et al.
MICROBIAL DRUG RESISTANCE (2019)
Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis
Sofia Maraki et al.
MYCOSES (2019)
Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol
Juliana Lirio et al.
BMJ OPEN (2019)
Antifungal Activity and Potential Mechanism of N-Butylphthalide Alone and in Combination With Fluconazole Against Candida albicans
Ying Gong et al.
FRONTIERS IN MICROBIOLOGY (2019)
Design and synthesis of mucoadhesive nanogel containing farnesol: investigation of the effect on HWP1, SAP6 and Rim101 genes expression of Candida albicans in vitro
Fatemeh Nikoomanesh et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species
J. D. Sobel et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model
Hamed Fakhim et al.
MYCOSES (2018)
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Adane Bitew et al.
BMC WOMENS HEALTH (2018)
Identification of nine cryptic species of Candida albicans, C. glabrata, and C. parapsilosis complexes using one-step multiplex PCR
Amir Arastehfar et al.
BMC INFECTIOUS DISEASES (2018)
Global burden of recurrent vulvovaginal candidiasis: a systematic review
David W. Denning et al.
LANCET INFECTIOUS DISEASES (2018)
Combination of Posaconazole and Amphotericin B in the Treatment of Candida glabrata Biofilms
Celia E. Rodrigues et al.
MICROORGANISMS (2018)
Farnesol signalling in Candida albicans - more than just communication
Melanie Polke et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2018)
The MNN2 Gene Knockout Modulates the Antifungal Resistance of Biofilms of Candida glabrata
Celia E. Rodrigues et al.
BIOMOLECULES (2018)
Combinatorial strategies for combating invasive fungal infections
Michaela Spitzer et al.
VIRULENCE (2017)
Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
Maiken Cavling Arendrup et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
The Effectiveness of Voriconazole in Therapy of Candida glabrata's Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression
Celia F. Rodrigues et al.
MYCOPATHOLOGIA (2017)
In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains
Jinping Xia et al.
BIOFOULING (2017)
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model
Aliz Bozo et al.
JOURNAL OF MICROBIOLOGY (2016)
Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches
Shu Yih Chew et al.
MYCOSES (2016)
How to bolster the antifungal pipeline
David W. Denning et al.
SCIENCE (2015)
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms
Aspasia Katragkou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Mechanisms of Antifungal Drug Resistance
Leah E. Cowen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Farnesol induces apoptosis-like cell death in the pathogenic fungus Aspergillus flavus
Xiaoyun Wang et al.
MYCOLOGIA (2014)
Effect of Farnesol on Growth, Ergosterol Biosynthesis, and Cell Permeability in Coccidioides posadasii
Raimunda Samia Nogueira Brilhante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol
Rossana A. Cordeiro et al.
MEDICAL MYCOLOGY (2013)
Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm
Li-hua Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicans
Monika Sharma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
An Evaluation of Risk Factors in Pregnant Women with Candida Vaginitis and the Diagnostic Value of Simultaneous Vaginal and Rectal Sampling
Ahmet Baris Guzel et al.
MYCOPATHOLOGIA (2011)
Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus
Joseph Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance
Mary Ann Jabra-Rizk et al.
FEMS YEAST RESEARCH (2006)
Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics
Marie V. Pirotta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedospotium prolificans isolates
J Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule
G Ramage et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2002)
Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol
JM Hornby et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Share Paper
